Mayur Ian Somaiya's Net Worth
$120 Thousand
Who is Mayur Ian Somaiya?
Mayur Ian Somaiya does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TCR2 THERAPEUTICS INC., and NewAmsterdam Pharma Co N.V..
SEC CIK
Mayur Ian Somaiya's CIK is 0001760303
Past Insider Trading and Trends
2020 was Mayur Ian Somaiya's most active year for acquiring shares with 5 total transactions. Mayur Ian Somaiya's most active month to acquire stocks was the month of November. 2020 was Mayur Ian Somaiya's most active year for disposing of shares, totalling 4 transactions. Mayur Ian Somaiya's most active month to dispose stocks was the month of October. 2019 saw Mayur Ian Somaiya paying a total of $21,241.50 for 153,973 shares, this is the most they've acquired in one year. In 2020 Mayur Ian Somaiya cashed out on 7,666 shares for a total of $179,980.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TCR2 THERAPEUTICS INC. No price found
Chief Financial OfficerMayur Ian Somaiya owns 1,473 units of Common Stock. In the year 2019 Mayur Ian Somaiya filed a total of 7 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$20.44 | -$58,240.00 | 1.47K |
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
| -53.07% | -1.67K |
$17.94 | -$98,220.00 | 1.47K |
Scheduled
|
Nov 17
| ||
Form 4
|
∞
| 3.14K |
$11.51 | $36,118.80 | 3.14K |
Aug 30 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NewAmsterdam Pharma Co N.V. (NAMS) Snapshot price: $16.4
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||